THYROCARE

Thyrocare Technologies Ltd.

565.55-1.1 (-0.20%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Thyrocare Technologies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Thyrocare Technologies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. 19 Aug 2026
    Disclosure under Regulation 30A of LODR
    Please find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
  2. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
  3. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
  4. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
  5. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201118 Aug 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual Fund
  6. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt Ltd
  7. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PAC
  8. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201117 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 17, 2026 for Docon Technologies Pvt Ltd
  9. General17 Aug 2026
    Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited
    Please refer the enclosed intimation letter
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201114 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
  11. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201114 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
  12. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
  13. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
  14. General13 Aug 2026
    Communication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited.
    Please refer the enclosed intimation letter.
  15. General13 Aug 2026
    Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares Of Thyrocare Technologies Limited
    Please find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company
  16. General24 Jul 2026
    Submission Of Machine-Readable Document Of Earlier Submitted Results Of The Company For The Quarter Ended On June 30, 2026
    Thyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30, 2026
  17. Newspaper Publication24 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30, 2026
  18. General23 Jul 2026
    Audio Recording Of Earnings Conference Call For The Quarter Ended June 30, 2026
    Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026
  19. General23 Jul 2026
    Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business ....
  20. General23 Jul 2026
    Re-Appointment Of Internal Auditor Of The Company
    Please find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.

Frequently Asked Questions

Where can I download the annual report of Thyrocare Technologies Ltd.?
Annual reports of Thyrocare Technologies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Thyrocare Technologies Ltd.?
Quarterly earnings results and presentations of Thyrocare Technologies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Thyrocare Technologies Ltd. publish earnings call transcripts?
Earnings call transcripts of Thyrocare Technologies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Thyrocare Technologies Ltd.?
Investor presentations and annual day presentations of Thyrocare Technologies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Thyrocare Technologies Ltd.?
Corporate announcements and regulatory filings of Thyrocare Technologies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Thyrocare Technologies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Thyrocare Technologies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Thyrocare Technologies Ltd.?
The ISIN (International Securities Identification Number) of Thyrocare Technologies Ltd. is INE594H01019. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Thyrocare Technologies Ltd. listed?
Thyrocare Technologies Ltd. is listed on NSE and BSE. The NSE symbol is THYROCARE and the BSE code is -.
Where can I find the shareholding pattern of Thyrocare Technologies Ltd.?
The quarterly shareholding pattern of Thyrocare Technologies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Thyrocare Technologies Ltd. on Sharpely?
Share price data for Thyrocare Technologies Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.